Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland – part II – expert based recommendations for surveillance and management of side-effects
Andreas Ziegler, Claudia Weiß, Katharina Vill, Matthias Baumann et autres